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ABSTRACT
ObjeCtives
To investigate whether moderate alcohol consumption 
has a favourable or adverse association or no 
association with brain structure and function.
Design
Observational cohort study with weekly alcohol intake 
and cognitive performance measured repeatedly over 
30 years (1985-2015). Multimodal magnetic resonance 
imaging (MRI) was performed at study endpoint 
(2012-15).
setting
Community dwelling adults enrolled in the Whitehall II 
cohort based in the UK (the Whitehall II imaging 
substudy).
PartiCiPants
550 men and women with mean age 43.0 (SD 5.4) at 
study baseline, none were “alcohol dependent” 
according to the CAGE screening questionnaire, and all 
safe to undergo MRI of the brain at follow-up. Twenty 
three were excluded because of incomplete or poor 
quality imaging data or gross structural abnormality 
(such as a brain cyst) or incomplete alcohol use, 
sociodemographic, health, or cognitive data.
Main OutCOMe Measures
Structural brain measures included hippocampal 
atrophy, grey matter density, and white matter 
microstructure. Functional measures included 
cognitive decline over the study and cross sectional 
cognitive performance at the time of scanning.
results
Higher alcohol consumption over the 30 year follow-up 
was associated with increased odds of hippocampal 
atrophy in a dose dependent fashion. While those 
consuming over 30 units a week were at the highest 
risk compared with abstainers (odds ratio 5.8, 95% 
confidence interval 1.8 to 18.6; P≤0.001), even those 
drinking moderately (14-21 units/week) had three 
times the odds of right sided hippocampal atrophy 
(3.4, 1.4 to 8.1; P=0.007). There was no protective 
effect of light drinking (1-<7 units/week) over 
abstinence. Higher alcohol use was also associated 
with differences in corpus callosum microstructure and 
faster decline in lexical fluency. No association was 
found with cross sectional cognitive performance or 
longitudinal changes in semantic fluency or word 
recall.
COnClusiOns
Alcohol consumption, even at moderate levels, is 
associated with adverse brain outcomes including 
hippocampal atrophy. These results support the recent 
reduction in alcohol guidance in the UK and question 
the current limits recommended in the US.
Introduction
Alcohol use is widespread and increasing across the 
developed world.1-3  It has historically been viewed as 
harmless in moderation,4  defined variably from 9-18 
units (72-144 g) a week.5 6  Recent evidence of associa-
tions with risk of cancer7  has prompted revision of UK 
government alcohol guidance, though US Federal 
Dietary guidelines (2015-20) allow up to 24.5 units a 
week for men.8  Even light drinking (midpoint <12.5g 
daily/8 units a week) has been associated with 
increased risk of oropharnygeal, oesophageal, and 
breast cancer.7 9  While chronic dependent drinking is 
associated with Korsakoff syndrome and alcoholic 
dementia,10 the long term effects of non-dependent 
alcohol consumption on the brain are poorly under-
stood. Robust evidence of adverse associations would 
have vital implications for public health.
Some authors have suggested an inverted U shaped 
relation between alcohol use and brain outcomes, sim-
ilar to that seen with cardiovascular disease. 
Light-to-moderate drinking has been associated with a 
lower risk of dementia11 12  and a reduced incidence of 
myocardial infarction13  and stroke.14  Brain imaging 
studies, however, have thus far failed to provide a con-
vincing neural correlate that could underpin any pro-
tective effect. Results of research into the effects of 
moderate alcohol on the brain are inconsistent.15  Mod-
erate alcohol consumption in older people has been 
WhAT IS AlReAdy knoWn on ThIS TopIC
Heavy drinking is associated with Korsakoff’s syndrome, dementia, and widespread 
brain atrophy
While smaller amounts of alcohol have been linked to protection against cognitive 
impairment, few studies have examined the effects of moderate alcohol on the brain
Previous studies have methodological limitations especially regarding the lack of 
prospective alcohol data, have been conflicting, and have failed to provide a 
convincing neural correlate
WhAT ThIS STudy AddS
Compared with abstinence, moderate alcohol intake is associated with increased 
risk of adverse brain outcomes and steeper cognitive decline in lexical fluency
The hippocampus is particularly vulnerable, which has not been previously linked 
negatively with moderate alcohol use
No protective effect was found for small amounts of alcohol over abstinence, and 
previous reports claiming a protective effect of light drinking might have been 
subject to confounding by associations between increased alcohol and higher 
social class or IQ
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associated with reduced total brain volume,16  increased 
ventricle size,17  grey matter atrophy,18  and reduced den-
sity of frontal and parietal grey matter,19 20  but others 
have not found such associations15  or only at higher 
consumptions.21  Associations between moderate alco-
hol consumption and white matter findings are also 
inconsistent. De Bruin and colleagues reported 
increased white matter volume in moderate drinkers 
compared with abstainers,22  whereas Anstey and col-
leagues found the inverse relation.23  Similarly, whereas 
increased white matter hyperintensities have been 
described in moderate drinkers compared with abstain-
ers,24  others found no association.17 23 25
Unresolved questions persist because of design limits 
to existing studies of non-dependent drinking and 
brain imaging. Alcohol consumption cannot be ran-
domised over long periods. Most studies to date have 
been cross sectional or with limited prospectively gath-
ered data on alcohol. People typically underestimate 
their alcohol intake,26 a problem likely to be worse in a 
retrospective study. Studies have also included elderly 
people, in whom sub-threshold presymptomatic cogni-
tive impairment might already have an impact on drink-
ing patterns.
We used data on alcohol consumption gathered pro-
spectively over 30 years to investigate associations with 
brain structural and functional outcomes in 550 non-al-
cohol dependent participants. Our hypotheses were 
twofold: light drinking (<7 units weekly) is protective 
against adverse brain outcomes and cognitive decline 
and heavier drinking (above recommended guidelines) 
is associated with adverse brain and cognitive out-
comes.
Methods
study design and participants
Five hundred and fifty people were randomly selected 
for the current Whitehall II imaging substudy (2012-15) 
from the Whitehall II cohort study.27 The Whitehall II 
study was established in 1985 at University College Lon-
don, with the aim of investigating the relation between 
socioeconomic status, stress, and cardiovascular 
health. It recruited 10 308 non-industrial civil servants 
across a range of employment grades. Sociodemo-
graphic, health, and lifestyle variables (including alco-
hol use) were measured over a follow-up period of 
about 30 years, at about five year intervals (phase 1: 
1985-88, phase 3: 1991-93, phase 5: 1997-99, phase 7: 
2003-04, phase 9: 2007-09, phase 11: 2011-12). To make 
the sample as representative as possible of the cohort at 
baseline, we drew a random list of 1380 participants 
from those who took part in the Whitehall II phase 11 
clinical examination or phase 10 pilot examination and 
had consented. Participants were sampled from high, 
intermediate, and low socioeconomic groups.
Alcohol variables collected in each phase included 
units drunk a week, frequency of drinking a week over 
the previous year, and results of the CAGE screening 
questionnaire.28  We used weekly consumption in this 
analysis as there is less likelihood of a ceiling effect in 
comparison with drinking frequency. We calculated 
average alcohol use across the study as mean consump-
tion a week averaged across all study phases. Partici-
pants were deemed “abstinent” if they consumed less 
than 1 unit of alcohol a week. “Light” drinking was 
defined as between 1 and <7 units a week and “moder-
ate” drinking as 7 to <14 units a week for women and 7 
to <21 units for men, based on use in the existing litera-
ture and government guidelines (fig 1 ). “Unsafe drink-
ing” was defined according to pre-2016 (21 units (168 g) 
a week for men and 14 units (112 g) for women) and 
newly revised UK Department of Health guidelines (>14 
units (112 g) for men and women) and further catego-
rised (14-20, 21-30, >30 units weekly) for the purposes of 
the logistic regression analysis.29 Non-dependent drink-
ers were defined as those scoring <2 on the CAGE ques-
tionnaire.
Age, sex, education, smoking, social activity—such 
as attendance at clubs and visits with family/friends, 
physical activity, voluntary work—and component mea-
sures of the Framingham stroke risk score—such as 
blood pressure, smoking, history of cardiovascular 
events, cardiovascular drugs—were assessed by self 
report questionnaire. Social class was determined 
according to occupation at phase 3 (highest class=1, 
lowest=4). Drugs (number of psychotropic drugs 
reported as taken) and lifetime history of major depres-
sive disorder (assessed by structured clinical interview 
for DSM IV) were assessed at the time of the scan. Infor-
mation about personality traits was determined by 
questionnaire at phase 1 and included trait impulsivity 
(question: “Are you hot-headed?”).
Cognitive function was assessed longitudinally at 
phases 3, 5, 7, 9, and 11 and at the time of scanning with 
lexical (how many words beginning with a specific let-
ter can be generated in one minute) and semantic (how 
many words in a specific category can be named in one 
minute) fluency tests. Short term memory recall (20 
words) was tested at phases 3, 5, 7, 9, and 11. Cross sec-
tional cognitive performance was measured at the time 
of the scan with the Montreal cognitive assessment 
1 unit contains 10 mL or 8 g of alcohol
14 units (UK guidance per week for men and women) is
  equivalent to 4 pints of high strength beer or 5 large glasses
  of 14% wine (see below)
24.5 units (US guidance for men) is equivalent to 7 pints of
  beer or 9 glasses of wine
Glass of wine
(175 mL), 14%
Pint of high
strength beer/
lager/cider
(568 mL), 5.2%
How much alcohol is there in a standard drink?
2.4 2.4 2.4 2.4 2.4
3.0 3.0 3.0 3.0
Fig 1 | uK 2016 guidelines on alcohol consumption (see 
www.alcoholconcern.org.uk/help-and-advice/help-and-
advice-with-your-drinking/unit-calculator/) (redrawn from 
alcohol Concern, 2016)
the bmj | BMJ 2017;357:j2353 | doi: 10.1136/bmj.j2353
RESEARCH
3
(MoCA, education adjusted), trail making test (TMT-A 
and B), Rey-Osterrieth complex figure (RCF) test (copy, 
immediate, delay, recognition), Hopkins verbal learn-
ing test (HVLT-R; immediate, delay), Boston naming 
test (BNT), and digit span and digit substitution test 
(DSST). Full scale IQ (FSIQ) was estimated at the time of 
the scan with the test of premorbid functioning-UK ver-
sion (TOPF-UK), with adjustment for sex and education.
Participants were included in the imaging substudy if 
they were safe to undergo MRI and able to give informed 
consent. Exclusions were due to incomplete or poor 
quality imaging data or gross structural abnormality 
(such as a brain cyst), incomplete data on alcohol use 
(>2 study phases data missing), and missing sociode-
mographic, health, or cognitive data (fig 2).
Mri analysis
All MRI scans were acquired at the functional magnetic 
resonance imaging of the brain (FMRIB) centre, Univer-
sity of Oxford, with a 3 Tesla Siemens Verio scanner 
(2012-15). We used T1-weighted and diffusion tensor 
(DTI) 3T MRI sequences for these analyses.30
Full technical details are in the appendix. In brief, we 
initially examined associations between alcohol use 
and grey matter using voxel based morphometry, an 
objective method to compare grey matter density 
between individuals in each voxel (smallest distin-
guishable image volume) of the structural image. For 
each participant for subsequent analyses we addition-
ally extracted hippocampal volumes (adjusted for total 
intracranial volume) using an automated segmenta-
tion/registration tool. Automated segmentation of the 
amygdala was less reliable in this sample so we did not 
use extracted volumes in this analysis. Three clinicians 
independently defined hippocampal atrophy according 
to visual rating (Scheltens score31) and reached a 
 consensus.
Diffusion tensor images indicate the directional pref-
erence of water diffusion in neural tissue and allow 
inferences about the structural integrity of white matter 
tracts. In healthy myelinated fibres diffusion is 
restricted perpendicular to the longitudinal axis of the 
fibre—that is, it is anisotropic. We carried out voxel-wise 
statistical analysis of diffusion tensor data (fractional 
anisotropy (FA), axial diffusivity (AD), radial diffusivity 
(RD), and mean diffusivity (MD)) using tract based spa-
tial statistics (TBSS).32
Outcomes
Primary outcomes were continuous measures of grey 
matter density in the voxel based morphometry analy-
sis and white matter integrity in the tract based spatial 
statistics analysis (fractional anisotropy, mean, radial, 
and axial diffusivity).
Visual ratings of hippocampal atrophy were dichoto-
mised into atrophy versus no atrophy based on 0/1 on 
the (4 point) Scheltens scale to reflect clinical use 
(“abnormal” versus “normal”).31 Hippocampal volume 
(%intracranial volume) was used as a continuous vari-
able in a multiple linear regression analysis.
As cognitive outcomes we used decline in short term 
memory, semantic and lexical fluency, and cross sec-
tional performance on Montreal cognitive assessment, 
trail making test, Rey-Osterrieth complex figure test, 
Hopkins verbal learning test, Boston naming test, digit 
span, and digit substitution test.
statistical analysis
All analyses were done with R,33 unless otherwise 
stated. To assess representativeness of included partic-
ipants we examined differences between included and 
excluded participants using t tests of means (continu-
ous variables) or χ2 tests of independence (categorical 
variables). According to variable type, we used means 
(standard deviations), medians (interquartile ranges), 
or numbers (percentages) to summarise sociodemo-
graphic and clinical measures for included participants 
who were split by safe versus unsafe average alcohol 
use averaged over all phases, on the basis of UK con-
temporary (pre-2016) guidelines. Significant differences 
between safe and unsafe drinkers in continuous vari-
ables were tested with t tests of means (normally dis-
tributed) or Wilcoxon rank sum tests (non-normally 
distributed), and in binary categorical variables (and 
mini-mental state examination, Montreal cognitive 
assessment, and Framingham stroke risk score, which 
have lower and upper bounds) with Fisher’s exact test 
of proportions. In view of small group numbers (<5) for 
social class, we performed a simulation test to estimate 
group differences.34 Weekly consumption of alcohol 
(units and grams) was described with means, standard 
deviations, medians, and interquartile ranges.
We examined alcohol trends over time using mixed 
effects modelling, with time from study baseline (phase 
1) as the independent variable and alcohol consumption 
(units/week) as the dependent variable. This method 
accounts for missing data and correlation of repeated 
measures (in this case alcohol use). We calculated inter-
cepts (baseline consumption) and slopes (trends over 
study) for each participant. The ability of other variables 
to predict longitudinal trends of alcohol consumption 
was tested by inclusion of the following in the mixed 
effects model: age, sex, education, premorbid IQ, social 
class, Framingham risk score (a composite measure 
Whitehall II Phase 11 participants (n=6306)
Participants with structural scan (n=550)
Participants included in all analyses except TBSS (n=527)
Participants included in TBSS analyses (n=511)
Random selection from Phase 10 (pilot) or 11 and consenting
for invitation to Oxford imaging sub-study (n=1380)
Structural abnormality, missing
alcohol or confounder data (n=23)
Missing or poor quality DTI images (n=16)
Fig 2 | Flow chart of participants included in analysis 
alcohol consumption and brain function
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including smoking, cardiovascular disease or diabetes, 
cardiovascular drugs), exercise frequency, club atten-
dance, voluntary work, visits with friends and family, 
lifetime history of major depressive disorder on the 
structured clinical interview for DSM IV (SCID) (yes-2/
no-1), and current psychotropic drugs (yes-2/no-1).
We included mean alcohol consumption (units/
week) across all study phases as an independent vari-
able in voxel based morphometry (grey matter density 
as dependent variable) and tract based spatial statistics 
analyses (FA/MD/RD/AD as dependent variable). Vox-
el-wise, we applied a generalised linear model (GLM) 
using permutation based non-parametric testing (ran-
domise),35 correcting for multiple comparisons across 
space (threshold-free cluster enhancement, TFCE).
We used two post hoc tests to confirm the associa-
tions between alcohol consumption and hippocampal 
size after the voxel based morphometry analysis. Firstly, 
we used logistic regression to calculate odds ratios for 
left and right hippocampal atrophy versus no atrophy 
(visual atrophy ratings based on a cut off of 0/1 on the 
Scheltens scale),31 given average alcohol consumption 
across study phases. The latter was categorised as absti-
nent (<1 unit, reference group), 1 to <7 units, 14 to <21 
units, 21 to <30 units, and >30 units a week. Secondly, 
we performed multiple linear regression with hippo-
campal volume (extracted from FIRST (an automated 
segmentation/registration tool), adjusted for intracra-
nial volume and transformed by squaring to normalise 
the residuals) as the dependent variable and alcohol 
consumption as an independent variable.
In all analyses with a brain measure as the depen-
dent variable, we included the following potential con-
founding variables (identified from knowledge of the 
literature) as independent variables: age, sex, premor-
bid IQ, education, social class, Framingham risk score, 
current psychotropic drugs (number), lifetime history of 
major depressive disorder (structured clinical inter-
view: yes-2/no-1), exercise frequency, club attendance, 
voluntary work, and visits with friends and family. In 
the subset with data on personality traits (n=179), anal-
yses were additionally adjusted for impulsiveness.
We used mixed effects models to model longitudinal 
cognitive data. For count data (word recall from list of 
20: “memory”) we used a binomial regression and for 
lexical and semantic fluency (performed within a cer-
tain time) we used Poisson regression. The following 
fixed effects were included: time from study baseline, 
average alcohol consumption across the study (absti-
nent (reference group, <1 unit weekly), 1- <7, 7- <14, 14- 
<21, >21), age, sex, education, social class, premorbid 
IQ, and Framingham stroke risk score. To test whether 
cognitive decline significantly differed between abstain-
ers and those with higher alcohol intakes, we added 
interaction terms between time and alcohol category. 
Contrasts between other categories of drinking were 
also checked to test for significant differences in cogni-
tive decline—for example, those drinking 1-<7 versus 
>21 units. We used Wald tests,36 37 estimating the overall 
effect of all interactions between alcohol and time on 
the models, to test the null hypothesis that rates of cog-
nitive decline did not differ between alcohol categories. 
Learning effects have been well demonstrated when the 
same cognitive test is presented more than once to a 
participant, which in our study could obscure true cog-
nitive decline. In an attempt to control for this we added 
a dummy variable to code for the first time the test was 
taken (First). We also dummy coded for the test being 
performed at Oxford (Oxford), as there was an atypi-
cally short time interval between phase 11 and the last 
measurement point, which we hypothesised could 
result in an increased learning effect. We included 
interaction terms for FSIQ*First and FSIQ*Oxford to 
check if learning effects differ with premorbid IQ. Par-
ticipant identification was included as a random effect. 
Usual diagnostic checks were performed on the models. 
The resulting coefficients from binomial regression 
equate to log(odds) and from Poisson regression to 
log(Poisson mean count). Exponentiated estimates are 
reported in the appendix. Regression coefficients were 
converted into interpretable differences in lexical 
decline per year compared with abstainers by: 100*(1−
(exp (estimates)). Models were visually presented with 
graphs to predict trends in cognitive test scores over the 
study for a “typical” participant: male, mean age 70, 15 
years’ education, social class I, IQ 118, and Framingham 
stroke risk score 10%.
We fitted regression models to check whether average 
alcohol consumption over the study (independent vari-
able) predicted cross sectional performance on a range 
of memory tests (dependent variable) performed at the 
study end point. Age, sex, education, and premorbid IQ 
were included as covariates. When the test score repre-
sented a continuous variable, we used multiple linear 
regression. For count data (such as digit coding), we 
initially fitted Poisson regression and checked for 
over-dispersion. If this was found, we used a negative 
binomial model. For the remainder of the tests, where 
the upper score is bounded, we initially fitted regres-
sion models using binomial distributions. If over-dis-
persion was in evidence we performed a folded 
transformation and checked for approximate normality 
using Q-Q plots of residuals. The same models were 
re-fitted with and without alcohol consumption, and a 
hypothesis test (likelihood ratio) was performed. 
 Calculated P values were used to test whether alcohol 
made a significant difference to the model.
Structural equation modelling (SEM; Amos 24 for 
Windows) was used post hoc for hypothesis testing and 
to generate fit statistics for models of relations between 
alcohol use, brain measures, and cognitive decline. 
This modelling allows simultaneous analysis of multi-
ple variables in one model, and time series with 
auto-correlated errors. The hypothesised underlying 
structure of the model was constructed following the 
voxel based morphometry, tract based spatial statistics, 
and mixed effects analyses, with average alcohol con-
sumption as an exogenous variable, hippocampal vol-
ume, corpus callosum mean diffusivity (generally the 
most sensitive measure of loss of white matter integ-
rity), and decline in lexical fluency (slopes from mixed 
effects model) included as endogenous variables (with 
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latent variables to account for measurement error). We 
modelled covariance of alcohol with sex and IQ and 
between brain measures. The model was improved by 
iteratively eliminating paths with P>0.1 and monitoring 
of the successive improvement of the model fits statis-
tics (χ2, comparative fit index, root mean square error of 
approximation, and the Tucker-Lewis index) until we 
identified the most parsimonious model.
In all analyses, results were judged significant if the 
adjusted P value was <0.05. Bootstrapping was per-
formed to derive 95% confidence intervals for estimates.
Patient involvement
Participants were from the Whitehall II cohort. No 
patients were involved in setting the research question 
or the outcome measures, nor were they involved in the 
design, recruitment, or conduct of the study. No 
patients were asked to advise on interpretation or writ-
ing up of results. Results were disseminated to the study 
participants in abstract format and as presentations at 
the 30th anniversary day for the Whitehall II cohort.
Results
Participants/descriptive data
Sociodemographic, health, and lifestyle data are 
reported for the 527 included participants, separated 
into alcohol consumption groups (table 1 ). Twenty 
three participants were excluded from the voxel based 
morphometry and visual ratings analyses on the basis 
of structural brain abnormalities, poor quality images, 
or missing confounder data (fig 2 ). A further 16 were 
excluded from the tract based spatial statistics analysis 
because of missing or poor quality diffusion tensor 
images. Excluded participants did not significantly 
 differ from those included on any of the reported char-
acteristics (data available on request). There was a 
higher proportion of men, and participants were 
slightly less educated, with higher blood pressure and 
lower measures of depressive symptoms compared with 
the larger Whitehall II cohort (see appendix table A). 
Mean age was 43.0 (SD 5.4) at the start of the study 
(appendix table B). Unsafe drinkers differed from safe 
drinkers by having a higher premorbid IQ, a higher per-
centage of men and smokers, and higher Framingham 
risk scores (table 1).
Median alcohol consumption across study phases 
(fig 3 and appendix table B) was 11.5 units (85.8 g) a 
week (interquartile range 6.2-18.8 units (51.7-154.3 g)) for 
men and 6.4 units (51.4 g) a week (2.8-11.9 units (22.7-
103.6 g)) for women. Weekly alcohol intake did not sig-
nificantly increase over the phases of the study for the 
group as a whole (change in weekly alcohol units per 10 
years of follow-up 0.15, 95% confidence interval −0.21 to 
0.51; P=0.4), but trends over time correlated with base-
line intake (intercepts and slopes correlated negatively 
(r= −0.43, 95% confidence interval −0.50 to −0.36)—that 
is, those drinking more at baseline tended to lower their 
consumption more over the course of the study, a find-
ing consistent with regression to the mean. Male sex 
(difference in weekly alcohol units compared with 
women 4.89, 2.54 to 7.19; P<0.001) and higher premor-
bid IQ (change in weekly alcohol units for every 1 IQ 
point 0.18, 0.06 to 0.30; P=0.004) predicted higher base-
line consumption but not changes in consumption with 
table 1 | baseline (phase 1 unless otherwise indicated) summary characteristics of 527 participants (unless marked) included in analysis by safe (<14 
units/week for women, <21 units/week for men) and unsafe alcohol consumption, defined by contemporaneous (pre-2016) uK Department of Health 
guidelines, on average over study duration
safe drinkers 
(n=428)
unsafe drinkers 
(n=99)
Difference between groups or 
other statistic (95% Ci)
Mean (SD) age at start (years) 43.0 (5.4) 42.8 (5.1) MD=0.2 (−1.0 to 1.4), P=0.7
No (%) of men 339 (79.2%) 85 (85.9%) OR=6.7 (−2.5 to 14.1), P=0.13
No (%) married* 308 (72.0%) 81 (81.8%) OR=9.8 (−0.2 to 18.2), P=0.05
Median (IQR) time in full time education (years) 14.0 (12 to 17.0) 14.8 (12.0 to 17.0) W statistic=19 448,† P=0.2
Mean (SD) full scale IQ (estimated from TOPF)*† 117.4 (10.6) 120.0 (8.3) MD=−2.6 (−4.5 to −0.7), P=0.009
No (%) by social class‡:
 1 62 (15.5) 21 (21.2)
Pearson statistic=7.4,§ P=0.4
 2 328 (76.6) 76 (76.8)
 3 34 (7.9) 2 (2.0)
 4 4 (0.9) 0
No (%) of smokers* 11 (2.6%) 11 (11.1%) OR=8.5 (2.7 to 16.5), P<0.001
Mean (SD) systolic blood pressure* 140.3 (17.8) 143.3 (16.7) MD=−3.0 (−6.9 to 0.8), P=0.1
Mean (SD) diastolic blood pressure* 76.3 (10.5) 77.7 (10.9) MD=−1.4 (−3.7 to 0.9), P=0.2
Median (IQR) Framingham stroke risk total score (10 year probability, %)* 9 (6.0 to 15.0) 11 (5.3 to 16.8) OR=2.0 (−4.2 to 10.3), P=0.5
No (%) with history of major depressive disorder (%)*§ 79 (18.5%) 16 (16.2%) OR=2.3 (−7.2 to 10.1), P=0.6
Mean (SD) social visits (weekly)* 4.4 (3.2) 3.9 (3.1) MD=0.5 (-0.2 to 1.2), P=0.2
No (%) taking psychotropic drugs* 62 (14.5%) 12 (12.1%) OR=2.4 (−6.3 to 9.2), P=0.5
Median (IQR) MoCA total (/30)* 28 (26.0 to 29.0) 28 (26.0 to 29.0) OR=0.0 (−1.7 to 4.5), P=1.0
Median (IQR) MMSE baseline total (/30)¶ 29 (28.0 to 30.0) 29 (28.0 to 30.0) OR=0.0 (−1.7 to 4.5), P=1.0
MD=mean difference; OR=odds ratio; MoCA=Montreal cognitive assessment.
*At time of scan.
†Test of premorbid function.
‡Social class based on occupation at phase 3: 1=professional, 2=managerial, 3=skilled non-manual, 4=skilled manual.
§Structured clinical interview for DSM IV (SCID).
¶Phase 7 (n=389).
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time. Other sociodemographic and clinical factors were 
not related to consumption. Average alcohol use over 
the study was over “safe limits” in 13.6% women and 
20.0% men, as judged by pre-2016 UK guidelines (>21 
units (168 g)/week for men, >14 units (112 g)/week for 
women), and 40.3% as judged by the 2016 revised UK 
guidelines (>14 units (112 g)/week for men and women) 
(see appendix for consumption data for single phases). 
Scores on the CAGE questionnaire were below the sen-
sitive screening cut off of 228 for all participants at all 
Whitehall II phases (appendix table C).
alcohol and brain structure
Higher alcohol use was associated with reduced grey 
matter density, hippocampal atrophy, and reduced 
white matter microstructural integrity.
Grey matter
Average alcohol consumption over the study (units/
week) was negatively correlated with grey matter den-
sity in the voxel based morphometry analyses, espe-
cially in hippocampi (fig 4), even after adjustment for 
multiple potential confounders. Associations also 
extended anteriorly into the amygdalae. Frontal regions 
were unaffected.
Compared with abstinence, higher alcohol consump-
tion was also associated with increased odds of abnor-
mally rated hippocampal atrophy (defined as score >0 
on Scheltens visual rating scale; table 2). This was a 
dose dependent effect. The highest odds were in those 
drinking in excess of 30 units a week (odds ratio 5.8, 
95% confidence interval 1.8 to 18.6; P≤0.001), but odds 
of atrophy were higher compared with abstinence even 
in those drinking at moderate levels of 7-<14 units a 
week (3.4, 1.4 to 8.1; P=0.007). There was no protective 
effect (that is, reduced odds of atrophy) with light drink-
ing (1-<7 units a week) over abstinence. Findings were 
similar in subanalyses of men alone but not in the 
smaller subgroup of women. The risk of right sided hip-
pocampal atrophy was significantly greater at >14 alco-
hol units a week compared with abstinence, but for left 
sided atrophy at only >30 units a week.
Mean hippocampal volumes (raw and adjusted for 
intracranial volume) were within the range cited in the 
literature (appendix table D)38-40 and correlated with 
visual ratings of hippocampal atrophy (Spearman’s 
r=−0.4; P<0.001). Consistent with voxel based mor-
phometry and visual ratings findings, alcohol con-
sumption independently predicted FIRST-extracted 
hippocampal volume (%ICV) (table 3). Exclusion of the 
three individual highest drinkers (>60 units weekly) did 
not substantially change the results (appendix table E). 
In the subset of participants for whom personality trait 
data were available from phase 1 (n=179), additionally 
adjustment for the analysis for trait impulsivity did not 
alter the findings.
White matter
Higher average alcohol consumption across the study 
was inversely associated with white matter integrity (fig 
5 ), reflected by lower corpus callosum fractional anisot-
ropy and higher radial, axial and mean diffusivity. 
These associations were focused on the anterior corpus 
callosum (genu and anterior body, fig 5).
alcohol and cognitive function
Higher alcohol consumption over the study predicted 
faster decline on lexical fluency but not semantic flu-
ency or word recall (fig 6). Those drinking 7-<14, 14-<21, 
and >21 units a week declined faster in terms of lexical 
scores than abstainers. This effect was independent of 
age, sex, premorbid IQ, education, social class, and 
Framingham stroke risk score.The size of the difference 
Alcohol consumption (weekly units)
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Fig 3 | Frequency distribution of alcohol consumption on 
average across study by sex
0.01 0.05P values
Fig 4 | results of voxel based morphometry (corrected for 
threshold-free cluster enhancement (tFCe)): significant 
negative correlation between weekly alcohol units 
(average of all phases across study) and grey matter 
density in 527 participants. adjusted for age, sex, 
education, premorbid iQ, social class, physical exercise, 
club attendance, social activity, Framingham stroke risk 
score, psychotropic drugs, and history of major depressive 
disorder
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can be interpreted as follows: people drinking 7-<14 
units experienced a 0.5% greater reduction from their 
baseline in lexical fluency per year (14% over 30 years), 
those drinking 14-<21 units 0.8% greater per year (17% 
over 30 years), and those drinking >21 units 0.6% per 
year (16% over 30 years) than abstainers (appendix 
table F). Though the three categories of higher con-
sumption (7-<14, 14-<21, and >21 units/week) showed 
significantly greater decline than abstainers, the only 
significant difference in trends between these three 
groups was between those drinking 14-21 units and 
those drinking 7-14 units (14-21 units experience 0.3% 
faster decline per year; P=0.02). There was no evidence 
to support light drinkers being relatively protected from 
cognitive decline compared with abstainers. Overall 
results of tests examining the question of whether rates 
of cognitive decline are linked to alcohol were signifi-
cant (after multiple comparisons correction) for lexical 
fluency (χ2=14.4; P=0.006) but not semantic fluency 
(χ2=10.0; P=0.04) or memory recall (χ2=9.8; P=0.04).
We found evidence of learning effects on lexical and 
categorical fluency tests (P≤0.01), such that the second 
time a participant was presented with a test they per-
formed better. This learning effect was predicted by pre-
morbid IQ (First*premorbid IQ P=0.002-0.02). 
There was a trend towards higher baseline perfor-
mance on lexical fluency and memory recall in those 
drinking compared with abstainers (appendix table F), 
but these findings did not reach significance after cor-
rection for multiple testing.
We did not find any significant relations between 
alcohol consumption and cross sectional performance 
table 2 | adjusted* odds ratios for left and right sided hippocampal atrophy on scheltens 
visual rating score (reference based on abstainers), with average alcohol consumption 
(abstinence (<1 unit) is reference category) in 527 participants. Figures are numbers with 
hippocampal atrophy and total numbers in drinking category with odds ratios (95% 
confidence interval), and P values
alcohol  
(units weekly)
right hippocampal atrophy (v none) left hippocampal atrophy (v none)
no (total) Or (95% Ci) P value no (total) Or (95% Ci) P value
Men
0-<1 9 (22) — — 12 (22) — —
1-<7 55 (99) 1.6 (0.6 to 4.3) 0.4 69 (99) 1.7 (0.6 to 4.8) 0.3
7-<14 68 (132) 1.7 (0.6 to 4.5) 0.3 85 (132) 1.5 (0.6 to 4.2) 0.4
14-<21 57 (86) 3.2 (1.1 to 9.3) 0.02 59 (86) 2.0 (0.7 to 5.7) 0.2
21-<30 38 (54) 3.9 (1.3 to 12.0) 0.02 39 (54) 2.2 (0.7 to 6.8) 0.2
≥30 24 (31) 5.2 (1.4 to 19.0) 0.01 27 (31) 6.3 (1.5 to 27.0) 0.01
Women
0-<1 4 (15) — — 7 (15) — —
1-<7 12 (41) 1.1 (0.2 to 5.6) 0.9 20 (41) 0.8 (0.2 to 3.6) 0.8
7-<14 19 (33) 3.1 (0.6 to 16.6) 0.2 22 (33) 2.0 (0.4 to 10.2) 0.4
14-<21 6 (11) 4.2 (0.6 to 28.8) 0.1 9 (11) 6.2 (0.7 to 55.2) 0.1
21-<30 1 (3) 1.1 (0.04 to 26.9) 1.0 2 (3) 0.4 (0.02 to 8.4) 0.4
≥30 4 (15) — — 7 (15) — —
Total
0-<1 13 (37) — — 19 (37) — —
1-<7 67 (140) 1.5 (0.7 to 3.4) 0.3 89 (140) 1.3 (0.6 to 3.0) 0.5
7-<14 87 (165) 2.0 (0.9 to 4.4) 0.1 107 (165) 1.4 (0.6 to 3.2) 0.4
14-<21 63 (97) 3.4 (1.4 to 8.1) 0.007 68 (97) 1.9 (0.8 to 4.6) 0.1
21-<30 39 (57) 3.6 (1.4 to 9.6) 0.009 41 (57) 1.9 (0.7 to 4.9) 0.2
≥30 24 (31) 5.8 (1.8 to 18.6) <0.001 27 (31) 5.7 (1.5 to 21.6) 0.01
*Adjusted for age, sex, premorbid IQ, education, social class, Framingham risk score, history of major depressive 
disorder (SCID), exercise frequency, club attendance, social visits, current use of psychotropic drugs.
table 3 | Multiple linear regression results, with squared 
hippocampal volume (% of intracranial volume) as 
dependent variable and average weekly alcohol 
consumption across study as independent variable
Change in volume for 
every 10 unit increase in 
consumption (95% Ci) P value
Unadjusted alcohol −0.26 (−0.37 to −0.15) <0.001
Adjusted alcohol* −0.19 (−0.30 to −0.08) <0.001
*Adjusted for age, sex, premorbid IQ, education, social class, marital 
status, Framingham stroke risk score, history of major depressive 
disorder (SCID), exercise frequency, club attendance, social visits, 
current use of psychotropic drugs.
0.01 0.05P values
Fractional anisotropy
Radial diusivity
Mean diusivity
Axial diusivity
Fig 5 | tract based spatial statistics results (corrected for 
threshold-free cluster enhancement, tFCe) showing 
negative correlation between average alcohol across study 
(all phases) and fractional anisotropy, and positive 
correlations with radial diffusivity, mean diffusivity, and 
axial diffusivity in 511 participants. adjusted for age, sex, 
education, premorbid iQ, social class, physical exercise, 
club attendance, social activity, Framingham stroke risk 
score, psychotropic drugs, and history of major depressive 
disorder
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on cognitive tests performed at the time of scanning (a 
summary of cognitive test performance and its relation 
to alcohol is given in appendix table H).
Modelling alcohol consumption and brain structure 
and function
To see how alcohol consumption and the associated 
brain regions interacted with cognitive decline, we used 
structural equation modelling. Hippocampal volume 
and corpus callosum mean diffusivity were included as 
exogenous variables. Age, sex, and premorbid FSIQ 
were also incorporated.
Removal of regression arrows from age, sex, premor-
bid IQ, and hippocampal volume to lexical fluency 
decline improved the model fit. Alcohol consumption 
independently predicted decline in lexical fluency. The 
final parsimonious model explained 21% of corpus cal-
losum mean diffusivity, 14% of right hippocampal vol-
ume, and 2% of lexical fluency decline variance (fig 7 , 
table 4), with good model fit. Alcohol consumption (in 
addition to age) predicted smaller hippocampal volume 
and greater corpus callosum mean diffusivity. Through 
its relation with corpus callosum mean diffusivity, and 
through a direct path, increased alcohol consumption 
predicted faster decline of lexical fluency.
discussion
Principal findings
We have found a previously uncharacterised dose 
dependent association between alcohol consumption 
over 30 years of follow-up and hippocampal atrophy, as 
well as impaired white matter microstructure. Addition-
ally, higher alcohol consumption predicted greater 
decline in lexical fluency but not in semantic fluency or 
word recall. There was no evidence of a protective effect 
of light drinking over abstinence on brain structure or 
function. The hippocampal findings were consistent 
between the brain-wide voxel based approach, auto-
matically extracted volumes, and clinical visual ratings 
of hippocampal atrophy. The relation was dose depen-
dent, and increased odds of hippocampal atrophy were 
found even in moderate drinkers (14-<21 units/week in 
men). The association between alcohol consumption 
and white matter microstructure in non-dependent 
drinkers is also novel and seemed to be driven by 
greater radial relative to axial diffusivity.
Corpus
callosum MD
-0.011
= Inverse associations
= Positive associations
-0.002
-0.017
0.038
0.003 Hippocampal
volume
Average
alcohol
Lexical fluency
decline
Age
Fig 7 | Final parsimonious structural equation model 
illustrating relations among alcohol consumption (average 
across study phases, as fraction of 100 units weekly), 
hippocampal volume (average, %intracranial volume), 
corpus callosum mean diffusivity (as multiplicative of 
1000), decline in lexical fluency (slopes), and age in 511 
participants. values on arrows represent unit changes in 
dependent variable for 1 unit increase in predictor. Model 
explained 21% of corpus callosum mean diffusivity, 14% of 
hippocampal variance, and 2% of lexical fluency decline 
variance (r2). Model fit: χ2=5.6, df=4, P=0.23, root mean 
square error of approximation=0.03, comparative fit 
index=0.99, tucker-lewis index=0.97
table 4 | Parameter estimates for paths in final structural equation model (fig 6), with their bias corrected 95% 
confidence intervals and P values, in 511 participants
Path Change in y for each unit 
increase in x (95% Ci) P valueFrom (x) to (y)
Average alcohol* Hippocampal volume −0.572 (−0.800 to −0.353) 0.01
Average alcohol Corpus callosum mean diffusivity† 0.038 (0.017 to 0.064) 0.009
Average alcohol* Lexical fluency decline −0.002 (−0.005 to 0.000) 0.08
Corpus callosum mean diffusivity† Lexical fluency decline −0.011 (−0.022 to −0.003) 0.003
Age Hippocampal volume −0.020 (−0.021 to −0.013) 0.008
Age Corpus callosum mean diffusivity2 0.003 (0.002 to 0.003) 0.03
*As fraction of 100 units weekly.
†As multiplicative of 1000.
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Fig 6 | Predicted longitudinal change in cognitive test 
scores (lexical and semantic fluency, word recall 
“memory”) for man of mean age (70) and premorbid iQ 
(118), median education (15 years), social class i and 
Framingham stroke risk score (10%) according to average 
alcohol consumption (weekly units). Predictions made on 
basis of mixed effects models with cognitive testing 
performed at phases 3, 5, 7, 9, and 11 and time of scan
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strengths and limitations
Strengths of this study are the 30 year longitudinal data 
on alcohol consumption and the detailed available data 
on confounders. Additional strengths include the avail-
ability of a large amount of MRI data and the advanced 
methods of imaging analysis. Grey matter findings were 
replicated with a voxel based approach, automated hip-
pocampal volumes, and visual ratings. Visual atrophy 
ratings are known to correlate closely with automated 
methods (own data) and are more applicable to clinical 
settings.41  In large neuroimaging studies, automatic 
segmentation is widespread.42 43  The automated 
approach we use (FIRST) has been shown to give accu-
rate and robust results.44
When interpreting these results, some caveats are 
necessary. While the sample comprised people living in 
the community, it might not be representative of the 
wider UK population. Most participants were educated 
and middle class men. The hippocampal atrophy asso-
ciations we found in the total sample were replicated in 
men alone but not in women. This could reflect a lower 
power to detect an effect in women, in part because the 
sample was dominated by men (a reflection of the sex 
disparity in the civil service in the 1980s) and in part 
because few of the included women drank heavily. This 
is an observational study as long term alcohol use can-
not be randomised. The Rosenthal effect could have 
influenced participants to lead healthier lifestyles as 
they were enrolled in the Whitehall II “stress and 
health” study. Data on alcohol use were self reported, 
and participants could have underestimated their 
drinking, though the longitudinal rather than cross sec-
tional approach often taken in other reported studies 
might minimise this,27  and the percentage of people 
drinking “unsafely” was comparable with that reported 
elsewhere.45-47  We used the CAGE screening instrument 
to identify alcohol dependence as it is well vali-
dated.28 48 There were 75 (14.2%) individuals with miss-
ing CAGE data from at least one phase, and we cannot 
exclude the possibility that we have included some peo-
ple who were alcohol dependent at points during the 
study period. All included individuals, however, had at 
least three (out of a total of five) CAGE measurements, 
and individuals with incomplete CAGE data on average 
drank significantly less than those with complete data 
(on a t test of means of 13.1 (SD 10.3) v 8.5 (SD 8.8) 
(P<0.001). Additionally, some participants reported 
drinking high levels of alcohol while screening negative 
on the CAGE, indicating a further possible inclusion of 
people with an alcohol use disorder in the sample. 
Increased odds of hippocampal atrophy and faster lexi-
cal fluency decline, however, were found even in those 
drinking moderate amounts. Although the alcohol and 
cognitive data were longitudinal, the analyses with MRI 
measures were cross sectional, raising the possibility 
that the associations between brain structure and alco-
hol were the result of a confounding variable. Longitu-
dinal imaging over more than a couple of years adds 
further confounders as the physical scanner and imag-
ing sequences are unlikely to be the same because of 
developments in MRI science, making results difficult 
to interpret. While efforts have been made to control for 
multiple potential sources of confounding, residual 
confounding from unmeasured sources is conceivable. 
To produce the adjusted associations we found, how-
ever, any uncontrolled confounders would need to be 
associated with both alcohol consumption and risk of 
brain abnormalities and unrelated to the multiple fac-
tors we controlled for. We cannot exclude the possibil-
ity, of unlikely face validity, that those with 
hippocampal atrophy at study baseline were more 
likely to drink more. Multiple testing and the possibility 
of a false positive is a concern when cognitive decline 
on three tests is performed. The small P values (range 
0.015-0.004) for lexical decline according to differing 
alcohol consumption, which reach significance with a 
strict Bonferroni correction (that is, a reduced signifi-
cance threshold of P<0.017), however, make this 
unlikely. In contrast, we cannot be as confident about 
the differences in baseline cognition for drinkers com-
pared with abstainers (P=0.03).
Finally, we fitted a structural equation model for 
alcohol, brain, and cognitive data that was defined post 
hoc. As such, results of previous analyses affected the 
choice of included variables meaning that the fit of the 
model might be overoptimistic.
Comparison with other studies
On average, 20% of men and 14% of women were drink-
ing above pre-2016 UK guidelines (>21 units/>14 units/
week, respectively). Other studies vary in reported rates 
of heavy drinking, but our rates are comparable.45 46 
Alcohol consumption might vary with country, as 
 highlighted by a study using the WHO global alcohol 
database.47
Hippocampal atrophy is a sensitive and relatively 
specific marker of Alzheimer’s disease,49  though it has 
also been reported in chronic alcoholics.19 50  The brain 
regions most vulnerable to alcohol abuse are said to be 
the frontal lobes.21  In our sample, higher but non-de-
pendent alcohol use was not associated with subse-
quent frontal brain atrophy or impaired cognition. Only 
the study by Den Heijer and colleagues has reported 
hippocampal findings in non-dependent drinkers.51 
This used a manual tracing rather than voxel based or 
visual rating approach to estimate hippocampal size. 
They reported a protective effect of moderate alcohol 
intake compared with abstinence, which conflicts with 
our results.19  Alcohol consumption, however, was 
determined cross sectionally, making it difficult to 
exclude reverse causation. In contrast, because of the 
longitudinal cognitive component of our study we 
could show an association between higher alcohol con-
sumption and cognitive decline. Additionally, several 
known confounders of hippocampal size, such as 
depression, were not controlled for in the Den Heijer 
study.51  Other studies in non-dependent drinkers have 
reported either no effect52 53  or a negative correlation 
with global grey matter but not hippocampal atro-
phy.17 18  In contrast with our first hypothesis and the 
findings of some other studies,11 12 19 54  we observed no 
evidence of a protective effect of light drinking 
doi: 10.1136/bmj.j2353 | BMJ 2017;357:j2353 | the bmj
RESEARCH
10
 compared with abstinence on brain structure or cogni-
tive function. Previous studies did not control for (pre-
morbid) IQ,11 12  and only a few for socioeconomic 
class.55-57  The observed protective effect could be due to 
confounding as we and others found a positive associa-
tion between alcohol intake and IQ.58  These factors sep-
arately predict better performance on cognitive tests. 
Supporting our second hypothesis, we found heavier 
alcohol consumption to be associated with adverse 
brain outcomes. The biological mechanism for this is 
unclear. Ethanol and acetaldehyde (a metabolite) are 
neurotoxic59  and cause reduced numbers60 61  and mor-
phological changes in hippocampal neurones in animal 
models.62  Associated thiamine and folate deficiency,63 
repeated head trauma, cerebrovascular events, liver 
damage, and repeated intoxication and withdrawal 
have also been implicated in more severe drinkers. The 
risk of hippocampal atrophy might be stronger and at 
lower levels of alcohol consumption for the right side. 
More severe hippocampal atrophy on the right has been 
described in those at higher risk of Alzheimer’s disease 
(asymptomatic ApoE4 homozygotes),64  as well as in 
those with mild cognitive impairment or Alzheimer’s 
disease.65  We found no structural laterality in associa-
tions with cognitive function. The literature on this is 
scarce and conflicting. Stronger associations between 
right hippocampal volume and visuospatial memory 
have been reported.66
The voxel based morphometry analysis also showed 
associations between increased alcohol consumption 
and reduced grey matter density in the amygdala. This 
result could not be confirmed with other methods as 
automated segmentation of these regions was unreli-
able, and we are unaware of any reliable visual atrophy 
rating scales. Amygdala atrophy has been described in 
those with Alzheimer’s disease67  and is implicated in 
preclinical models of alcohol misuse,68  alcohol abuse 
relapse,69  and in abstinent alcoholics,70  though others 
have found no association with lower levels of con-
sumption.53
In animals, radial diffusivity reflects differences in 
myelination.71 72  Previous studies have highlighted the 
corpus callosum as an area affected in fetal alcohol syn-
drome73  and in chronic alcoholism in Marchiafa-
va-Bignami disease.74 75  One study reported increased 
mean diffusivity in the amygdala in a post hoc analysis 
of female non-dependent drinkers.25  We are not aware 
of any studies investigating microstructural changes in 
white matter in moderate drinkers using a data driven 
skeletonised tract approach to diffusion tensor images, 
such as tract based spatial statistics. Alternative vox-
el-wise methods could compromise optimal analysis of 
multiple participants as there are alignment problems 
causing potential difficulties with interpretation of vox-
el-wise statistics.32
Participants drinking higher levels of alcohol over 
the study experienced a faster decline of lexical flu-
ency compared with abstainers. Lexical fluency 
involves selecting and retrieving information based 
on spelling (orthography) and has characteristically 
been associated with frontal executive function,76  in 
contrast with semantic fluency, which could depend 
more on temporal lobe integrity.77  The distinction 
might not be as clear cut, however, as functional net-
works overlap.78  The inverse relation between alcohol 
consumption and lexical decline was perhaps unsur-
prising given the frontal predominance of the nega-
tive associations with white matter integrity. We 
suggest two possibilities for the lack of more wide-
spread associations with cognition, particularly with 
semantic fluency and short term memory decline, 
given the structural brain findings (hippocampal atro-
phy). Firstly, there are clear practice effects over the 
study—that is, at least some participants improve 
their performance after repeated testing, and this is 
positively associated with premorbid IQ. This might 
be greater for the semantic compared with lexical flu-
ency tests. Variables predicting the ability to learn 
could be different from those protecting against cog-
nitive impairment because of a neurodegenerative 
process. Though we attempted to control for both IQ 
and learning effects, this might be insufficient to 
remove the confounding effect if a third variable, such 
as diet, mediates the relation between IQ and learning 
but is not in the model. Secondly, the brain changes 
might reflect an intermediate phenotype, and cogni-
tive change is not yet evident. It is now well docu-
mented that hippocampal atrophy precedes 
symptoms in those with Alzheimer’s dementia by sev-
eral years,79 so a similar phenomenon in alcohol 
related changes is  plausible.
Conclusions and policy implications
Prospective studies of the effects of alcohol use on the 
brain are few, and replication of these findings in other 
populations will be important. Alcohol consumption 
for individuals was remarkably stable across the study 
phases. This sample was therefore underpowered to 
detect differences in those considerably changing their 
intake from others who drink consistently. Investiga-
tions with larger numbers are needed to clarify whether 
there are graded risks between short versus long peri-
ods of higher alcohol consumption.
The finding that alcohol consumption in moderate 
quantities is associated with multiple markers of 
abnormal brain structure and cognitive function has 
important potential public health implications for a 
large sector of the population. For example, in our 
sample nearly half of the men and a quarter of the 
women were currently drinking in this range. Addi-
tionally, drinking habits were remarkably stable over a 
30 year period, suggesting that risky drinking habits 
might be embarked on in midlife. Recommended 
guidelines for drinking remained unchanged in the UK 
from 1987 until 2016. Our findings support the recent 
reduction in UK safe limits and call into question the 
current US guidelines, which suggest that up to 24.5 
units a week is safe for men, as we found increased 
odds of hippocampal atrophy at just 14-21 units a 
week, and we found no support for a protective effect 
of light consumption on brain structure. Alcohol 
might represent a modifiable risk factor for cognitive 
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impairment, and primary prevention interventions 
targeted to later life could be too late.
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